Business
Else Nutrition Upgraded to OTCQX Best Market
Else Nutrition Upgraded to OTCQX Best Market Canada NewsWire VANCOUVER, BC, July...
About this update from Else Nutrition Holdings Inc
[{"type":"text","content":"\n\n\n\nElse Nutrition Upgraded to OTCQX Best Market\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nVANCOUVER, BC, July 24, 2020\n\n\n\nVANCOUVER, BC, July 24, 2020 /CNW/ - Else Nutrition Holdings Inc. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (\"Else\" or the \"Company\"), is pleased to announce that its common shares have been approved for trading on the OTCQX® Best Market, a U.S. market operated by the OTC Markets Group. Else Nutrition's shares were previously traded on the OTCQB® Venture Market.\n\n \n \n \n \n \n \n\n \n\"We are very excited to have qualified to upgrade our US trading to the OTCQX Market,\" commented Ms. Hamutal Yitzhak, Else Nutrition CEO and Co-Founder. \"We believe that trading on the OTCQX Market will further raise visibility of Else Nutrition in the US and international marketplace as well as enhance trading liquidity and expand our shareholder base.\"\nThe OTCQX Market is designed for established, investor-focused companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Graduating to the OTCQX Market from the OTCQB Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among U.S. and international investors.\nThe Company also announces that its board of directors has approved on the issuance of incentive stock options (collectively, the \"Options\") to a number of its directors, officers, employees and consultants to purchase up to a total of 1,462,250 common shares in the capital of the Company (each, a \"Common Share\"). Of such Options, an aggregate of 687,500 Options are allocated to the directors and officers. This is a normal-course option grant that comprises part of the long-term compensation and retention incentives provided by the Company. \nEach Option is exercisable into one Common Share up to five years from the issuing date at a price of CND $2.19 per Common Share or in the case of 72,000 Options to be gr...